YTHDF2 and autoimmune hepatitis: In autoimmune hepatitis (AIH), upregulation of YTHDF2 decreases the expansion, chemotaxis, and suppressive function of bone-marrow-derived suppressor cells (MDSCs), offering a distinctive therapeutic target for immune-mediated hepatitis [228].